82 related articles for article (PubMed ID: 12379755)
1. The expression of WT1 in the differentiation of rhabdomyosarcoma from other pediatric small round blue cell tumors.
Carpentieri DF; Nichols K; Chou PM; Matthews M; Pawel B; Huff D
Mod Pathol; 2002 Oct; 15(10):1080-6. PubMed ID: 12379755
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic Utility of GATA3 and ISL1 in Differentiating Neuroblastoma From Other Pediatric Malignant Small Round Blue Cell Tumors.
Mohanty SK; Diwaker P; Mishra SK; Jha S; Lobo A; Panda SP; Sharma S; Kumar M; Arora S; Mallik V; Jain D; Jain E; Chakrabarti I; Varshney J; Beg A; Dixit M; Baisakh MR; Naik S; Sahoo SK; Akgul M; Balzer BL; Amin MB; Parwani AV
Int J Surg Pathol; 2024 Apr; 32(2):294-303. PubMed ID: 37312579
[TBL] [Abstract][Full Text] [Related]
3. Wilms tumor suppressor 1 (WT1) and early growth response 1 (EGR1) are regulators of STIM1 expression.
Ritchie MF; Yue C; Zhou Y; Houghton PJ; Soboloff J
J Biol Chem; 2010 Apr; 285(14):10591-6. PubMed ID: 20123987
[TBL] [Abstract][Full Text] [Related]
4. Chemotherapy and terminal skeletal muscle differentiation in WT1-mutant Wilms tumors.
Royer-Pokora B; Beier M; Brandt A; Duhme C; Busch M; de Torres C; Royer HD; Mora J
Cancer Med; 2018 Apr; 7(4):1359-1368. PubMed ID: 29542868
[TBL] [Abstract][Full Text] [Related]
5. Role of Cyclooxygenase-2 Pathway in Creating an Immunosuppressive Microenvironment and in Initiation and Progression of Wilms' Tumor.
Maturu P; Jones D; Ruteshouser EC; Hu Q; Reynolds JM; Hicks J; Putluri N; Ekmekcioglu S; Grimm EA; Dong C; Overwijk WW
Neoplasia; 2017 Mar; 19(3):237-249. PubMed ID: 28254151
[TBL] [Abstract][Full Text] [Related]
6. High Expression of WT1 and Low Expression of p53 in Archived Blocks of Children with Wilms Tumor in South Western Uganda.
Ssenkumba B; Atwiine B; Mitala Y; Adongo J; Olowo S; Nabulya R; Diaz Anaya A; Atwine R
Cancer Manag Res; 2024; 16():127-136. PubMed ID: 38476972
[TBL] [Abstract][Full Text] [Related]
7. The people behind the papers - Marina Ramiro-Pareta and Ofelia Martinez-Estrada.
Development; 2023 Mar; 150(6):. PubMed ID: 36971305
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical detection of WT1 protein in a variety of cancer cells.
Nakatsuka S; Oji Y; Horiuchi T; Kanda T; Kitagawa M; Takeuchi T; Kawano K; Kuwae Y; Yamauchi A; Okumura M; Kitamura Y; Oka Y; Kawase I; Sugiyama H; Aozasa K
Mod Pathol; 2006 Jun; 19(6):804-14. PubMed ID: 16547468
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical findings in embryonal small round cell tumors with molecular diagnostic confirmation.
Sebire NJ; Gibson S; Rampling D; Williams S; Malone M; Ramsay AD
Appl Immunohistochem Mol Morphol; 2005 Mar; 13(1):1-5. PubMed ID: 15722786
[TBL] [Abstract][Full Text] [Related]
10. Phase II clinical trial of Wilms tumor 1 peptide vaccination for patients with recurrent glioblastoma multiforme.
Izumoto S; Tsuboi A; Oka Y; Suzuki T; Hashiba T; Kagawa N; Hashimoto N; Maruno M; Elisseeva OA; Shirakata T; Kawakami M; Oji Y; Nishida S; Ohno S; Kawase I; Hatazawa J; Nakatsuka S; Aozasa K; Morita S; Sakamoto J; Sugiyama H; Yoshimine T
J Neurosurg; 2008 May; 108(5):963-71. PubMed ID: 18447714
[TBL] [Abstract][Full Text] [Related]
11. WT1 expression level and clinical factors in multiple myeloma.
Hatta Y; Takeuchi J; Saitoh T; Itoh T; Ishizuka H; Iriyama N; Miyajima T; Kaneita Y; Saiki M; Yasukawa K; Yasukawa R; Kura Y; Nishinarita S; Sawada U; Horie T
J Exp Clin Cancer Res; 2005 Dec; 24(4):595-9. PubMed ID: 16471322
[TBL] [Abstract][Full Text] [Related]
12. Immunophenotype of desmoplastic small round cell tumors as detected in cases with EWS-WT1 gene fusion product.
Zhang PJ; Goldblum JR; Pawel BR; Fisher C; Pasha TL; Barr FG
Mod Pathol; 2003 Mar; 16(3):229-35. PubMed ID: 12640103
[TBL] [Abstract][Full Text] [Related]
13. Aberrant expression of epithelial and neuroendocrine markers in alveolar rhabdomyosarcoma: a potentially serious diagnostic pitfall.
Bahrami A; Gown AM; Baird GS; Hicks MJ; Folpe AL
Mod Pathol; 2008 Jul; 21(7):795-806. PubMed ID: 18487991
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical profiling of Wilms tumor: a tissue microarray study.
Vasei M; Moch H; Mousavi A; Kajbafzadeh AM; Sauter G
Appl Immunohistochem Mol Morphol; 2008 Mar; 16(2):128-34. PubMed ID: 18227731
[TBL] [Abstract][Full Text] [Related]
15. Round cell sarcomas - biologically important refinements in subclassification.
Mariño-Enríquez A; Fletcher CD
Int J Biochem Cell Biol; 2014 Aug; 53():493-504. PubMed ID: 24801613
[TBL] [Abstract][Full Text] [Related]
16. Adrenocortical carcinoma: a comprehensive immunohistochemical study of 40 cases.
Weissferdt A; Phan A; Suster S; Moran CA
Appl Immunohistochem Mol Morphol; 2014 Jan; 22(1):24-30. PubMed ID: 23531850
[TBL] [Abstract][Full Text] [Related]
17. High prevalence of Wilms tumor 1 expression in multiple myeloma and plasmacytoma: A cohort of 142 Asian patients' samples.
Phikulsod P; Sukpanichnant S; Kunacheewa C; Chieochansin T; Junking M; Yenchitsomanus PT
Pathol Oncol Res; 2023; 29():1610844. PubMed ID: 36760714
[TBL] [Abstract][Full Text] [Related]
18. Incidence and Prognostic Impact of WT-1 Gene Exon7 and 9 Mutations in Acute Promyelocytic Leukemia.
Nejatifar F; Rostami S; Chahardouli B; Kasaeian A; Vaezi M; Kamranzadeh H; Mousavi SA; Farbod A; Alimoghaddam K; Ghavamzadeh A
Int J Hematol Oncol Stem Cell Res; 2022 Apr; 16(2):74-80. PubMed ID: 36304735
[No Abstract] [Full Text] [Related]
19. Diagnosis of soft tissue tumors using immunohistochemistry as a surrogate for recurrent fusion oncoproteins.
Black MA; Charville GW
Semin Diagn Pathol; 2022 Jan; 39(1):38-47. PubMed ID: 34750023
[TBL] [Abstract][Full Text] [Related]
20. Wilms' Tumor 1 (WT1): A Novel Immunomarker of Dermatofibrosarcoma Protuberans-An Immunohistochemical Study on a Series of 114 Cases of Bland-Looking Mesenchymal Spindle Cell Lesions of the Dermis/Subcutaneous Tissues.
Piombino E; Broggi G; Barbareschi M; Castorina S; Parenti R; Bartoloni G; Salvatorelli L; Magro G
Cancers (Basel); 2021 Jan; 13(2):. PubMed ID: 33445443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
